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Introduction
Zollinger-Ellison syndrome is a rare disorder caused by a 
tumor called a gastrinoma. The tumor secretes the hor-
mone gastrin, which causes excess production of  gastric 
acid, leading to severe recurrent ulcers of  the esophagus, 
stomach, duodenum, and jejunum. The rarity of  the syn-
drome may render the diagnosis difficult to make, especially 
since most radiologists are not aware of  this entity. About 
85% to 90% of gastrinomas are present within the “gastri-
noma triangle.” When the Zollinger-Ellison syndrome is 
suspected, physicians have to try to identify the tumor in 
the pancreas or the bowel. An In-111 penteteotide scan is 
the current technique of  choice. However, even using the 
technique of  SPECT/CT, the location may be missed or 
masked by peripheral anatomic structures in the gastri-
noma triangle. We hope to raise awareness of  the disease 
and of  a dual-isotope display as the method to identify the 
gastrinoma in the gastrinoma triangle.
Case report
  A 50-year-old man was admitted because of  abdominal 
cramps, vomiting, and watery diarrhea with up to 10 bowel 
movements. His medical history included 10 years of  pep-
tic ulcer disease, abdominal pain, and diarrhea, leading to 
a presumptive diagnosis of  irritable bowel disease. A year 
earlier, he had an episode of  upper gastrointestinal bleed-
ing. For the prevention of  relapsing peptic ulcer, he had 
been taking Nexium® (esomeprazole, a proton-pump in-
hibitor) thereafter. Esophagogastroduodenal endoscopy 
(performed for investigation of  the gastric symptoms) re-
vealed diffuse erosive esophagitis and duodenal ulcer, and 
absence of  Helicobacter pylori infection. Colonoscopy was 
reported as normal. A gallium-67 scan, made for a tumor 
survey, failed to exhibit active lesions. His baseline gastrin 
levels were measured at 900 pg/mI, with an increase to 
more than 1200 pg/mI after an IV secretin test. Further 
laboratory evaluation excluded multiple endocrine neopla-
sia type 1 syndrome.
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angle,” which is composed of  the porta hepatis, duodenal sweep, and pancreatic head. As surgery re-
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loop. Operative resection was performed, and a primary pancreatic gastrinoma was diagnosed by im-
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nique of  choice. This dual-isotope display permits a visual perception of  anatomic landmarks around the 
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A further approach to investigating the etiology of  the 
hypergastrinemia (an In-111 pentetreotide scan) showed an 
avid focus at the epigastrium (Fig. 1, open arrow), besides 
physiologic uptake in the kidneys and the spleen. For ease 
of  lesion mapping, the patient was asked to drink a mouth-
ful of  water with Tc-99m pertechnetate added. Dual-
isotope planar images were acquired simultaneously, center-
ing on the two In-111 photopeaks (170 & 245 keV) and on 
the Tc-99m photopeak (140-keV). The Tc-99m abdomen 
images were displayed to be the background maps (Fig. 2, A 
& B). The In-111 image was superimposed onto a Tc-99m 
image (Fig. 2, C & D), which showed that the pathologic 
focus was next to the duodenum and inside the gastrinoma 
triangle (1).  Subsequent CT revealed a 2.7×2.4-cm, lobu-
lated, enhancing lesion at the pancreas head (Fig. 3). Op-
erative resection was performed. Pathological examination 
revealed a gastrin-producing neuroendocrine tumor. The 
tumor cells were immunoreactive with chromogranin-A, 
synaptophysin, and gastrin. The patient’s serum gastrin 
level returned to normal (60 pg/ml) at 6-week followup, 
consistent with a surgical cure of  Zollinger-Ellison 
syndrome.
Discussion
 Gastrinomas are an integral part of  the Zollinger-Ellison 
syndrome (1, 2). The tumors produce large amounts of  
gastrin, triggering gastric acid hypersecretion, refractory 
peptic ulcers, and diarrhea. Recent data suggest that 65% 
of  gastrinomas are malignant, and up to 30% to 40% of  
patients will have evident metastatic disease at initial pres-
entation (3-5), requiring accurate preoperative localization 
of  the tumor (6). Gastrinomas are postulated to originate 
from stem cells of  the ventral pancreatic bud (7), as a result 
of  aberration of  neuroendocrine cells during normal em-
bryonic rotation of  the ventral pancreas (7, 8). Conse-
quently, 85% to 90% of  gastrinomas lie within the gastri-
noma triangle (9), comprising the porta hepatis, duodenal 
sweep, and pancreatic head (Fig. 3). 
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Figure 2. Pentetreotide imaging plus abdomen scintigrams. 
The patient was asked to drink a mouthful of water with Tc-
99m pertechnetate added. Dual-isotope planar images 
were acquired simultaneously, centering on the In-111 pho-
topeaks and on the Tc-99m photopeak. The Tc-99m abdo-
men images were displayed to be the background maps (A 
and B). The In-111 image was superimposed onto a Tc-99m 
image (C and D), which showed that the pathologic focus 
was next to the duodenum and inside the gastrinoma 
triangle.
Figure 1. An In-111 pentetreotide scan showed an avid fo-
cus at the epigastrium (open arrow), besides physiologic 
uptake in the kidneys and the spleen.
Functioning neuroendocrine tumors are characterized by 
presenting symptoms and signs in their early stages, while 
the lesions are small. Precise localization of  small foci is 
difficult. Somatostatin receptors are found on 80% of  gas-
trinomas. Therefore, a pentetreotide scan, which uses an 
analog of  somatostatin, has successfully localized these 
neoplasms (primary or nodal metastases) in up to 78% to 
86% of  cases (10-12). Gibril et al. studied 80 patients and 
found that CT, MRI, or angiography identified extrahe-
patic gastrinomas in 28% to 31% of  patients, and ultra-
sound detected extrahepatic tumors in 9% of  patients (13). 
The role of  pentetreotide scan is not just for localization of  
primary lesions, but also for screening of  metastases, and 
monitoring therapeutic response (13). 
In the current era of  multimodality imaging, SPECT/
CT plays an important role in localizing small lesions. One 
major drawback of  SPECT/CT imaging is additive ioniz-
ing radiation from the CT procedure. The estimated radia-
tion dose of  CT from SPECT/CT is variable because of  
the many factors involved. Briefly, for one SPECT bed posi-
tion, the effective dose to the chest and abdomen is around 
4 mSv. In case of  a CT for a two-bed SPECT/CT, the ap-
propriate effective dose values are added together (14). Be-
sides, the artifacts caused by any movement of  the patient 
or bowel movement would reduce the sensitivity, especially 
for small pancreatic tumors. Combining Tc-99m MDP and 
In-111 pentetreotide studies into a single display, which 
showed more information, has previously been suggested 
(15). Similarly, our technique does not increase time con-
sumption or significant radiation delivered to the patient, 
and can be easily implemented on any nuclear medicine 
workstation with minimal data acquisition. It is a rather 
straightforward display that permits a visual perception of  
anatomic landmarks around the lesion. 
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Figure 3. Abdomen CT axial (A) and coronal (B) images showing a 2.7×2.4-cm, 
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